Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery

Nanoparticle-mediated siRNA delivery is a complex process that requires transport across numerous extracellular and intracellular barriers. As such, the development of nanoparticles for efficient delivery would benefit from an understanding of how parameters associated with these barriers relate to the physicochemical properties of nanoparticles. Here, we use a multiparametric approach for the evaluation of lipid nanoparticles (LNPs) to identify relationships between structure, biological function, and biological activity. Our results indicate that evaluation of multiple parameters associated with barriers to delivery such as siRNA entrapment, pKa, LNP stability, and cell uptake as a collective may serve as a useful prescreening tool for the advancement of LNPs in vivo. This multiparametric approach complements the use of in vitro efficacy results alone for prescreening and improves in vitro–in vivo translation by minimizing false negatives. For the LNPs used in this work, the evaluation of multiple parameters enabled the identification of LNP pKa as one of the key determinants of LNP function and activity both in vitro and in vivo. It is anticipated that this type of analysis can aid in the identification of meaningful structure–function–activity relationships, improve the in vitro screening process of nanoparticles before in vivo use, and facilitate the future design of potent nanocarriers.

[1]  S. Milstein,et al.  Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation , 2013, Cancer Immunology, Immunotherapy.

[2]  C. Alabi,et al.  Attacking the genome: emerging siRNA nanocarriers from concept to clinic. , 2012, Current opinion in pharmacology.

[3]  Daniel G. Anderson,et al.  FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes. , 2012, ACS nano.

[4]  Juliane Nguyen,et al.  Nucleic acid delivery: the missing pieces of the puzzle? , 2012, Accounts of chemical research.

[5]  Y. J. Kwon Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency. , 2012, Accounts of chemical research.

[6]  Shigeo Matsuda,et al.  Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** , 2012, Angewandte Chemie.

[7]  Farnaz Niroui,et al.  In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery. , 2012, ACS nano.

[8]  M. B. Banaszak Holl,et al.  Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. , 2012, Molecular pharmaceutics.

[9]  J. Ritter,et al.  Abstract 67: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Results for ALN-PCS, a Novel RNAi Therapeutic for the Treatment of Hypercholesterolemia , 2012, Arteriosclerosis, Thrombosis, and Vascular Biology.

[10]  Daniel G. Anderson,et al.  Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells , 2012, Molecular therapy. Nucleic acids.

[11]  Daniel G. Anderson,et al.  Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.

[12]  Vineet Kumar,et al.  Nanocarriers: a tool to overcome biological barriers in siRNA delivery , 2011, Expert opinion on biological therapy.

[13]  D. Levorse,et al.  Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[14]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[15]  D. Levorse,et al.  Ionization behavior of amino lipids for siRNA delivery: determination of ionization constants, SAR, and the impact of lipid pKa on cationic lipid-biomembrane interactions. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[16]  K. G. Rajeev,et al.  Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  J. Au,et al.  Delivery of siRNA Therapeutics: Barriers and Carriers , 2010, The AAPS Journal.

[18]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[19]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[20]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[21]  E. Wagner,et al.  Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. , 2009, Bioconjugate chemistry.

[22]  T. Kissel,et al.  Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Michael S. Goldberg,et al.  Development of lipidoid-siRNA formulations for systemic delivery to the liver. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  Mark E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. , 2009, Molecular pharmaceutics.

[25]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[26]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[27]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[28]  K. Braeckmans,et al.  A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[29]  G. Sczakiel,et al.  Cellular uptake and intracellular release are major obstacles to the therapeutic application of siRNA: novel options by phosphorothioate-stimulated delivery , 2007, Expert opinion on biological therapy.

[30]  Darren H. Wakefield,et al.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes , 2007, Proceedings of the National Academy of Sciences.

[31]  A. Klippel,et al.  A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium , 2006, Gene Therapy.

[32]  Mark E. Davis,et al.  Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging , 2006, Nucleic acids research.

[33]  J. Heyes,et al.  Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  A. Urtti,et al.  Cell‐surface glycosaminoglycans inhibit cation‐mediated gene transfer , 2004, The journal of gene medicine.

[35]  N. Demaurex pH Homeostasis of cellular organelles. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[36]  D. Lauffenburger,et al.  Quantitative analysis of synthetic gene delivery vector design properties. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  A. Urtti,et al.  Extracellular Glycosaminoglycans Modify Cellular Trafficking of Lipoplexes and Polyplexes* , 2001, The Journal of Biological Chemistry.

[38]  P. Cullis,et al.  Modulation of membrane fusion by asymmetric transbilayer distributions of amino lipids. , 1994, Biochemistry.

[39]  W. H. Evans,et al.  Phospholipid, cholesterol, polypeptide and glycoprotein composition of hepatic endosome subfractions. , 1985, The Biochemical journal.

[40]  N. Dhalla,et al.  Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. , 1970, Molecular pharmacology.

[41]  N. Demaurex Homeostasis of cellular organelles , 2022 .